JP2011520894A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011520894A5 JP2011520894A5 JP2011509615A JP2011509615A JP2011520894A5 JP 2011520894 A5 JP2011520894 A5 JP 2011520894A5 JP 2011509615 A JP2011509615 A JP 2011509615A JP 2011509615 A JP2011509615 A JP 2011509615A JP 2011520894 A5 JP2011520894 A5 JP 2011520894A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- administered
- rhcc10
- composition according
- nasal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 18
- 239000007921 spray Substances 0.000 claims 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 201000009890 sinusitis Diseases 0.000 claims 2
- 239000001488 sodium phosphate Substances 0.000 claims 2
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims 1
- 208000000592 Nasal Polyps Diseases 0.000 claims 1
- 206010040744 Sinus headache Diseases 0.000 claims 1
- 229940035676 analgesics Drugs 0.000 claims 1
- 239000000730 antalgic agent Substances 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940125715 antihistaminic agent Drugs 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 230000001580 bacterial effect Effects 0.000 claims 1
- 229960000686 benzalkonium chloride Drugs 0.000 claims 1
- 229960004217 benzyl alcohol Drugs 0.000 claims 1
- 235000019445 benzyl alcohol Nutrition 0.000 claims 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 238000004140 cleaning Methods 0.000 claims 1
- 230000006835 compression Effects 0.000 claims 1
- 238000007906 compression Methods 0.000 claims 1
- -1 comprising a RhCC1 0 Substances 0.000 claims 1
- 239000000850 decongestant Substances 0.000 claims 1
- 229940124581 decongestants Drugs 0.000 claims 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims 1
- 229910000397 disodium phosphate Inorganic materials 0.000 claims 1
- 235000019800 disodium phosphate Nutrition 0.000 claims 1
- 239000003172 expectorant agent Substances 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 230000002262 irrigation Effects 0.000 claims 1
- 238000003973 irrigation Methods 0.000 claims 1
- 229940065725 leukotriene receptor antagonists for obstructive airway diseases Drugs 0.000 claims 1
- 239000003199 leukotriene receptor blocking agent Substances 0.000 claims 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims 1
- 235000019799 monosodium phosphate Nutrition 0.000 claims 1
- 230000000510 mucolytic effect Effects 0.000 claims 1
- 229940066491 mucolytics Drugs 0.000 claims 1
- 208000016366 nasal cavity polyp Diseases 0.000 claims 1
- 239000008219 nasal excipient Substances 0.000 claims 1
- 230000000306 recurrent effect Effects 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims 1
- 150000003431 steroids Chemical class 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 239000005526 vasoconstrictor agent Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5286108P | 2008-05-13 | 2008-05-13 | |
| US61/052,861 | 2008-05-13 | ||
| PCT/US2009/043613 WO2009140269A2 (en) | 2008-05-13 | 2009-05-12 | Recombinant human cc10 and compositions thereof for use in the treatment of nasal rhinitis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011520894A JP2011520894A (ja) | 2011-07-21 |
| JP2011520894A5 true JP2011520894A5 (enExample) | 2012-06-21 |
| JP5773437B2 JP5773437B2 (ja) | 2015-09-02 |
Family
ID=41319290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011509615A Active JP5773437B2 (ja) | 2008-05-13 | 2009-05-12 | 鼻性鼻炎の治療に使用するための組換えヒトｃｃ１０およびその組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20110240012A1 (enExample) |
| EP (2) | EP3085382A1 (enExample) |
| JP (1) | JP5773437B2 (enExample) |
| KR (1) | KR20110014199A (enExample) |
| CN (1) | CN102292099A (enExample) |
| AU (1) | AU2009246543B2 (enExample) |
| BR (1) | BRPI0911945A2 (enExample) |
| CA (1) | CA2724277A1 (enExample) |
| IL (1) | IL208940A0 (enExample) |
| MX (1) | MX2010012234A (enExample) |
| NZ (2) | NZ600803A (enExample) |
| WO (1) | WO2009140269A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060281681A1 (en) | 1997-05-28 | 2006-12-14 | Pilon Aprile L | Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |
| CN102292099A (zh) | 2008-05-13 | 2011-12-21 | 科拉森斯公司 | 在鼻炎治疗中使用的重组人cc10及其组合物 |
| US9168285B2 (en) | 2009-10-15 | 2015-10-27 | Therabron Therapeutics, Inc. | Recombinant human CC10 protein for treatment of influenza and ebola |
| EP2488205B1 (en) * | 2009-10-15 | 2016-09-21 | Clarassance, Inc. | Recombinant human cc10 protein for treatment of influenza |
| WO2012170842A2 (en) | 2011-06-09 | 2012-12-13 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Peptide for protection of allergic respiratory disorders |
| CA2928035C (en) | 2012-12-27 | 2024-07-02 | Massachusetts Eye & Ear Infirmary | Treatment of rhinosinusitis with p-glycoprotein inhibitors |
| PE20200404A1 (es) * | 2013-03-15 | 2020-02-26 | Janssen Pharmaceutica Nv | Composicion farmaceutica de clorhidrato de s-ketamina |
| WO2016205430A1 (en) * | 2015-06-15 | 2016-12-22 | Therabron Therapeutics, Inc. | Recombinant human cc10 protein facilitates repair and protects against damage to the respiratory epithelium due to exposure to both cigarette and other smoke |
| JP7085485B2 (ja) | 2016-01-15 | 2022-06-16 | マサチューセッツ アイ アンド イヤー インファーマリー | 分泌型ｐ－糖タンパク質は、慢性鼻副鼻腔炎の非侵襲的バイオマーカーである |
| CN113543827B (zh) * | 2019-02-27 | 2025-01-21 | 奥蒂卡拉股份有限公司 | 用于治疗鼻、鼻腔鼻窦和鼻咽组织感染和/或炎症的方法 |
| WO2020178653A1 (en) | 2019-03-05 | 2020-09-10 | Janssen Pharmaceuticals, Inc. | Esketamine for the treatment of depression |
| US12295933B2 (en) | 2019-03-25 | 2025-05-13 | Massachusetts Eye And Ear Infirmary | Methods and compositions to treat and diagnose diseases or pathologies associated with inflammation of the sinuses and nasal cavity |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4691009A (en) | 1984-12-26 | 1987-09-01 | Repligen Corporation | Hybrid proteins produced by an ultrahigh prokaryotic expression system |
| WO1987002367A2 (en) | 1985-10-18 | 1987-04-23 | The Upjohn Company | Cyclic hydrocarbons with an aminoalkyl sidechain |
| US4820514A (en) | 1985-12-30 | 1989-04-11 | Texas A&M University System | Low dosage of interferon to enhance vaccine efficiency |
| JP2656944B2 (ja) | 1987-04-30 | 1997-09-24 | クーパー ラボラトリーズ | タンパク質性治療剤のエアロゾール化 |
| US5266562A (en) | 1987-11-19 | 1993-11-30 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Anti-inflammatory agents |
| US5354269A (en) | 1991-12-20 | 1994-10-11 | Fibrogenex, Inc. | Method for treating cancer resections |
| US5491130A (en) | 1992-11-10 | 1996-02-13 | The United States Of America As Represented By The Department Of Health And Human Services | Peptide inhibitors of fibronectin and related collagen-binding proteins |
| US5482930A (en) | 1993-06-09 | 1996-01-09 | The Regents Of The University Of California | Anti-inflammatory composition and method with des-Tyr dynorphin and analogues |
| US5470885A (en) | 1993-09-29 | 1995-11-28 | The Research Foundation Of The State University Of New York | Fluorocarbons as anti-inflammatory agents |
| FR2724665B1 (fr) | 1994-09-16 | 1996-12-20 | Rhone Poulenc Rorer Sa | Procede de production de proteines recombinantes, plasmides et cellules modifiees |
| US5935860A (en) | 1995-03-07 | 1999-08-10 | The George Washington University | Use of uteroglobin expression as a molecular marker for prostatic intraepithelial neoplasia |
| US5696092A (en) | 1995-03-07 | 1997-12-09 | George Washington University | Methods and compositions for inhibiting metastasis of epithelial cell-derived cancers |
| WO1997001627A1 (en) | 1995-06-27 | 1997-01-16 | Igen International, Inc. | High-level expression and efficient recovery of ubiquitin fusion proteins from escherichia coli |
| US5817750A (en) | 1995-08-28 | 1998-10-06 | La Jolla Cancer Research Foundation | Structural mimics of RGD-binding sites |
| WO1997034997A1 (en) | 1996-03-21 | 1997-09-25 | Human Genome Sciences, Inc. | Human endometrial specific steroid-binding factor i, ii and iii |
| AU5253998A (en) | 1996-11-13 | 1998-06-03 | Board Of Regents, The University Of Texas System | Diminishing viral gene expression by promoter replacement |
| US20040047857A1 (en) | 1997-05-28 | 2004-03-11 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US20020160948A1 (en) * | 1998-07-21 | 2002-10-31 | Aprile Pilon | Recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| US7122344B2 (en) | 1997-05-28 | 2006-10-17 | Claragen, Inc. | Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| US20030207795A1 (en) | 1997-05-28 | 2003-11-06 | Pilon Aprile L. | Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions |
| US20030008816A1 (en) | 1997-05-28 | 2003-01-09 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US20060025348A1 (en) | 1997-05-28 | 2006-02-02 | Pilon Aprile L | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| US6255281B1 (en) | 1997-05-28 | 2001-07-03 | Claragen, Inc. And U.S. Government | Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| US20060281681A1 (en) | 1997-05-28 | 2006-12-14 | Pilon Aprile L | Methods and compositions for the reduction of neutrophil influx and for the treatment of bronchpulmonary dysplasia, respiratory distress syndrome, chronic lung disease, pulmonary fibrosis, asthma and chronic obstructive pulmonary disease |
| US20050261180A1 (en) | 1997-05-28 | 2005-11-24 | Pilon Aprile L | Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| US20020169108A1 (en) | 1997-05-28 | 2002-11-14 | Pilon Aprile L. | Methods and compositions for the treatment of fibrotic conditions & impaired lung function & to enhance lymphocyte production |
| JP4949552B2 (ja) | 1998-04-16 | 2012-06-13 | エンサイシブ・フアーマシユーテイカルズ，インコーポレイテツド | インテグリンのそれの受容体への結合を阻害するｎ，ｎ−ジ置換アミド |
| WO2000072868A2 (en) | 1999-06-01 | 2000-12-07 | Prendergast Patrick T | Peptides for therapeutic use |
| AU1582401A (en) | 1999-11-04 | 2001-05-14 | Human Genome Sciences, Inc. | Uteroglobin-like polynucleotides, polypeptides, and antibodies |
| CA2405946A1 (en) | 2000-04-14 | 2001-10-25 | Claragen, Inc. | Methods and compositions for the treatment of fibrotic conditions and impaired lung function and to enhance lymphocyte production |
| US20020025510A1 (en) | 2000-07-26 | 2002-02-28 | Strongin Alex Y. | Screening methods based on superactivated alpha V beta 3 integrin |
| WO2003057257A1 (en) * | 2002-01-02 | 2003-07-17 | The Johns Hopkins University | Cc10 inhibits th2 cytokines and eotaxins involved in allergic diseases |
| US20090227025A1 (en) | 2003-06-06 | 2009-09-10 | The Board Of Regents Of The University Of Texas System | Ex vivo human lung/immune system model using tissue engineering for studying microbial pathogens with lung tropism |
| EP1789067B8 (en) * | 2004-08-12 | 2012-08-15 | Helsinn Healthcare S.A. | Use of growth hormone secretagogues for stimulating the motility of the gastrointestinal system |
| EP2086560A4 (en) * | 2006-11-02 | 2012-03-28 | Riolan Technologies Inc | METHODS OF TREATING EPIPHORA |
| EP1935242A1 (en) * | 2006-12-21 | 2008-06-25 | Philip Morris Products S.A. | Transgenic animal model |
| WO2009126623A2 (en) | 2008-04-08 | 2009-10-15 | Amyris Biotechnologies, Inc. | Expression of heterologous sequences |
| CN102292099A (zh) | 2008-05-13 | 2011-12-21 | 科拉森斯公司 | 在鼻炎治疗中使用的重组人cc10及其组合物 |
| EP2488205B1 (en) | 2009-10-15 | 2016-09-21 | Clarassance, Inc. | Recombinant human cc10 protein for treatment of influenza |
-
2009
- 2009-05-12 CN CN2009801169194A patent/CN102292099A/zh active Pending
- 2009-05-12 EP EP16164414.1A patent/EP3085382A1/en not_active Withdrawn
- 2009-05-12 WO PCT/US2009/043613 patent/WO2009140269A2/en not_active Ceased
- 2009-05-12 KR KR1020107028003A patent/KR20110014199A/ko not_active Ceased
- 2009-05-12 NZ NZ600803A patent/NZ600803A/en not_active IP Right Cessation
- 2009-05-12 AU AU2009246543A patent/AU2009246543B2/en not_active Ceased
- 2009-05-12 EP EP09747353A patent/EP2303308A4/en not_active Ceased
- 2009-05-12 CA CA2724277A patent/CA2724277A1/en not_active Abandoned
- 2009-05-12 NZ NZ588895A patent/NZ588895A/en not_active IP Right Cessation
- 2009-05-12 MX MX2010012234A patent/MX2010012234A/es active IP Right Grant
- 2009-05-12 JP JP2011509615A patent/JP5773437B2/ja active Active
- 2009-05-12 BR BRPI0911945A patent/BRPI0911945A2/pt not_active IP Right Cessation
-
2010
- 2010-10-26 IL IL208940A patent/IL208940A0/en unknown
- 2010-11-12 US US12/945,622 patent/US20110240012A1/en not_active Abandoned
-
2016
- 2016-02-12 US US15/042,790 patent/US9844580B2/en active Active
-
2017
- 2017-11-10 US US15/809,357 patent/US20180125931A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011520894A5 (enExample) | ||
| JP5773437B2 (ja) | 鼻性鼻炎の治療に使用するための組換えヒトｃｃ１０およびその組成物 | |
| EA200802012A1 (ru) | Фармацевтические препараты в форме раствора для дозирующих ингаляторов под давлением | |
| Desrosiers | Refractory chronic rhinosinusitis: pathophysiology and management of chronic rhinosinusitis persisting after endoscopic sinus surgery | |
| US20160166505A1 (en) | Methods And Compositions For Treatment Of Respiratory Tract Infections | |
| AU2010335594B2 (en) | Synergistic antiviral composition and use thereof | |
| BR0108730A (pt) | Sistema, dispositivo e método para administração de uma droga, bocal de um dispositivo de administração de droga, dispositivo para administração de doses unitárias múltiplas de uma droga, métodos para preparação de um sistema de administração de droga e de uma formulação de droga e para tratamento de um paciente que necessita de doses múltiplas de uma droga, formulação de droga e multiparticulados | |
| NZ606383A (en) | Methods of treating pulmonary disorders with liposomal amikacin formulations | |
| PL2043637T3 (pl) | Sposoby i leki do podawania ibuprofenu | |
| NZ612063A (en) | Dental anesthetic comprising tetracaine and a vasoconstrictor for intranasal administration | |
| EP4609912A3 (en) | New use of a combination of sacubitril and valsartan | |
| WO2011094504A4 (en) | Antimicrobial sinus irrigation compositions, methods, and devices | |
| HRP20181079T1 (hr) | Sirnk i njena primjena u metodama i kompozicijama za liječenje i/ili prevenciju očnih stanja | |
| CN108472375A (zh) | 中重度流感的治疗方法 | |
| US10959964B2 (en) | Use of a sprayable composition comprising ambroxol | |
| JP5572110B2 (ja) | 粘膜の疾患および障害の予防および処置のための液体製剤 | |
| CN101947229A (zh) | 一种用于治疗鼻炎的药物组合物 | |
| FI3976012T3 (fi) | Ketamiinin intranasalinen annostus klusteripäänsärkypotilaille | |
| CN1242744C (zh) | 一种治疗常年性变态反应鼻炎的鼻腔制剂 | |
| JP2010519274A5 (enExample) | ||
| TW201249427A (en) | Use of sprayable composition containing ambroxol | |
| RU2023125283A (ru) | Фармацевтические композиции, содержащие флурбипрофен | |
| JP2015512439A5 (enExample) | ||
| HRP20191847T1 (hr) | Sastav antitijela protiv il-17ra i terapijski režimi za liječenje psorijaze | |
| CN1861088A (zh) | 鼻炎鼻窦炎滴鼻液 |